His lab is focusing on refining the alanine-scanning assay to some crucial residues that may properly distinguish in between fibrils from neurodegenerative tauopathies. He envisions utilizing this streamlined assay for postmortem neuropathological analysis, And maybe for blood screening of tauopathi